Skip to menu Skip to content Skip to footer

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING.

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

Gobe, G. C., Johnson, D. W., Li, J., Pat, B. K., Percy, C. J. and Rajandram, R. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

2008

Conference Publication

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

Gobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology.

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

2008

Conference Publication

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

Brooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell.

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Implementation of the routine reporting of eGFR in Australia and New Zealand

Jones, Graham R. D., Mathew, Timothy, Johnson, David and Peake, Michael (2008). Implementation of the routine reporting of eGFR in Australia and New Zealand. 11th Bergmeyer Conference, Eibsee, 2008. Taylor & Francis. doi: 10.1080/00365510802144953

Implementation of the routine reporting of eGFR in Australia and New Zealand

2008

Conference Publication

Immuno-histochemical profiling of clear cell renal cell carcinoma: A tissue microarray study

Rajandram, R., Perry-Keene, J., Campbell, C., Johnson, D. and Gobe, G. (2008). Immuno-histochemical profiling of clear cell renal cell carcinoma: A tissue microarray study. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x

Immuno-histochemical profiling of clear cell renal cell carcinoma: A tissue microarray study

2008

Conference Publication

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

Rajandram, R., Pat, B. K., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

2008

Conference Publication

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell .

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

2008

Conference Publication

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

Percy, Christine, Brown, L., Johnson, D. W. and Gobe, G. (2008). Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing. Australian and New Zealand Society of Nephrology (ANZSN) Annual Conference, Newcastle, Australia, 6-10 September 2008.

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

2008

Conference Publication

Intradermal versus intramuscular hepatitis B vaccination in haemodialysis patients: A prospective, open label randomized controlled trial in patients unresponsive to primary vaccination

Wiggins, K., Van Eps, C., Barraclough, K., Whitby, M., Carpenter, S., Johnson, D., Johnson, C. H. and Playford, G. (2008). Intradermal versus intramuscular hepatitis B vaccination in haemodialysis patients: A prospective, open label randomized controlled trial in patients unresponsive to primary vaccination. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell.

Intradermal versus intramuscular hepatitis B vaccination in haemodialysis patients: A prospective, open label randomized controlled trial in patients unresponsive to primary vaccination

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May, 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease

Bennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. HOBOKEN: Australian and New Zealand Society of Nephrology (ANZSN). doi: 10.1111/j.1440-1797.2008.001013.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease

2008

Conference Publication

An in vitro study of the effects of medicinal plant extracts on renal cells: Potential therapeutic and toxic effects of herbal extracts

Wojcikowski, K., Wohlmuth, H., Johnson, D. W., Rolfe, M. and Gobe, G. C. (2008). An in vitro study of the effects of medicinal plant extracts on renal cells: Potential therapeutic and toxic effects of herbal extracts. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2008.00954.x

An in vitro study of the effects of medicinal plant extracts on renal cells: Potential therapeutic and toxic effects of herbal extracts

2008

Conference Publication

Off-label use of rituximab in a tertiary referral renal unit

Miles, R., Butterly, S., Pillans, P., Sturtevant, J., Johnson, D., Campbell, S., Hawley, C., Mudge, D. and Van Eps, C. (2008). Off-label use of rituximab in a tertiary referral renal unit. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, NSW Australia, 6-10 September 2008. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Off-label use of rituximab in a tertiary referral renal unit

2008

Conference Publication

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

Kaisar, M., Armstrong, K., Prins, J., Marwick, T., Johnson, D., Hawley, C. and Isbel, N. (2008). The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell.

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients